Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660–73

Lorenzo Marconi; Thomas B. Lam; Axel Bex; Börje Ljungberg; Alessandro Volpe

doi:10.1016/j.eururo.2016.04.026

Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660–73

Lorenzo Marconi, Thomas B. Lam, Axel Bex, Börje Ljungberg, Alessandro Volpe

Risultato della ricerca: Contributo su rivista › Lettera › peer review

Lingua originale	Inglese
pagine (da-a)	e141-e142
Rivista	European Urology
Volume	70
Numero di pubblicazione	5
DOI	https://doi.org/10.1016/j.eururo.2016.04.026
Stato di pubblicazione	Pubblicato - 2016
Pubblicato esternamente	Sì

Accesso al documento

10.1016/j.eururo.2016.04.026

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Marconi, L., Lam, T. B., Bex, A., Ljungberg, B., & Volpe, A. (2016). Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660–73. European Urology, 70(5), e141-e142. https://doi.org/10.1016/j.eururo.2016.04.026

@article{d6fa18f09e4d4b55b718495f1f1240e6,

title = "Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660–73",

author = "Lorenzo Marconi and Lam, {Thomas B.} and Axel Bex and B{\"o}rje Ljungberg and Alessandro Volpe",

note = "Funding Information: Lorenzo Marconi and Alessandro Volpe have nothing to disclose. Thomas B. Lam has received consultancy fees and speaker honoraria from Pfizer, GlaxoSmithKline, Astellas, and Ipsen. Axel Bex has received speaker honoraria, consultancy fees, and research/grant support from Pfizer; has received consultancy fees from Novartis; has participated in advisory boards for GlaxoSmithKline and Novartis; and has participated in trials sponsored by Pfizer Europe. Borje Ljungberg has received speaker honoraria from GlaxoSmithKline, Roche, Pfizer, and Novartis; has participated in trials sponsored by GlaxoSmithKline, Medivation, Pfizer, and Janssen; and has participated in advisory boards for Pfizer and GlaxoSmithKline.",

year = "2016",

doi = "10.1016/j.eururo.2016.04.026",

language = "English",

volume = "70",

pages = "e141--e142",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "5",

}

Marconi, L, Lam, TB, Bex, A, Ljungberg, B & Volpe, A 2016, 'Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660–73', European Urology, vol. 70, n. 5, pagg. e141-e142. https://doi.org/10.1016/j.eururo.2016.04.026

Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660–73. / Marconi, Lorenzo; Lam, Thomas B.; Bex, Axel et al.
In: European Urology, Vol. 70, N. 5, 2016, pag. e141-e142.

Risultato della ricerca: Contributo su rivista › Lettera › peer review

TY - JOUR

T1 - Reply to Jae Heon Kim's Letter to the Editor re

T2 - Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660–73

AU - Marconi, Lorenzo

AU - Lam, Thomas B.

AU - Bex, Axel

AU - Ljungberg, Börje

AU - Volpe, Alessandro

N1 - Funding Information: Lorenzo Marconi and Alessandro Volpe have nothing to disclose. Thomas B. Lam has received consultancy fees and speaker honoraria from Pfizer, GlaxoSmithKline, Astellas, and Ipsen. Axel Bex has received speaker honoraria, consultancy fees, and research/grant support from Pfizer; has received consultancy fees from Novartis; has participated in advisory boards for GlaxoSmithKline and Novartis; and has participated in trials sponsored by Pfizer Europe. Borje Ljungberg has received speaker honoraria from GlaxoSmithKline, Roche, Pfizer, and Novartis; has participated in trials sponsored by GlaxoSmithKline, Medivation, Pfizer, and Janssen; and has participated in advisory boards for Pfizer and GlaxoSmithKline.

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=84964828670&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2016.04.026

DO - 10.1016/j.eururo.2016.04.026

M3 - Letter

SN - 0302-2838

VL - 70

SP - e141-e142

JO - European Urology

JF - European Urology

IS - 5

ER -